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Target cell lysis can be achieved by different specific effector mechanisms: antibody 
and complement (complement-dependent lysis, [CDL]I), ant ibody and K cells (anti- 
body-dependent cell-mediated cytotoxicity, [ADCC]) or cytolytic T lymphocytes 
(CTL). Little is known about how the target antigens have to be presented on the cell 
membrane to allow specific target cell lysis and whether the different effector 
mechanisms have similar structural requirements for cytolysis. We have studied these 
questions in a model system in which purified viral spike proteins were used as target 
cell antigens. We were particularly interested in finding out whether it is sufficient 
that viral antigens are bound to cells or whether integration of the viral antigens into 
the lipid bilayer of the plasma membrane is a prerequisite for cytolysis. Our  earlier 
data (1, 2) indicated that viral antigen integration is required for lysis by H-2- 
restricted CTL.  In this report we studied this question with respect o cytolytic events 
involving antibodies. 
We have used Semliki Forest virus (SFV), a membrane  virus which is assembled by 
a budding process. SFV has only one spike protein, composed of three polypeptide 
chains, which is inserted into the plasma membrane at the budding site. This spike 
protein can be prepared from purified SFV in three different physical forms: (a) as a 
monomer bound to detergent (3), (b) as a practically lipid- and detergent-free protein 
micelle in an octamerous form (29S complex) (4), or (c) reconstituted into detergent- 
free lipid vesicles--so-called virosomes (5). 
The micelles and most likely also the virosomes attach to receptors on the cell 
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surface, which are shown to be the histocompatibility antigens (6). The requirements 
of viral antigen expression on tumor target cells for immune cytolysis were studied by 
comparing target cells for immune cytolysis were studied by comparing target cells 
prepared in three different ways: (a) virus-infected cells, where the antigens are 
integrated into the cell membrane from within, (b) cells bearing the viral antigens 
attached to receptors on the cell surface, and (c) cells which have the viral antigens 
integrated into the cell membrane from the outside by fusion of target cells with 
virosomes. Because the virosomes did not fuse spontaneously with the cell membrane, 
we used Sendai virus to facilitate the fusion (Fig. 1). 
Immune cytolysis of  target cells was measured by the 5aCr-release technique after 
incubation with either anti-viral antibodies and complement (CDL) or anti-virus 
antibody and K cells (ADCC). In addition, in selected experiments anti-virus CTL  
were also employed. We will show that viral antigen binding to cells is not sufficient 
and that integration of viral glycoproteins i a prerequisite for anti-viral immune 
cytolysis in all three assays investigated. 
Mater ia ls  and  Methods  
Virus and Preparation of Virus Antigen. A prototype strain of SFV was propagated inmonolayer 
cell cultures of BHK-21 cells. The culture procedure, virus purification, and purity controls 
were performed as described by K/i~iri~iinen et al. (7). The lipid-free octamer membrane protein 
complexes (protein micelles), which have an s of 29S (therefore also referred to as 29S 
complexes), were prepared by solubilization of whole virus with Triton X-100 followed by 
centrifugation through a top-layer zone of Triton X-100 into a 20-50% sucrose gradient 
according to Helenius and Bonsdorff (4). Liposomes with inserted virus spike proteins (viro- 
somes) were prepared with the octylglycoside ialysis method of Helenius et al. (5). The protein 
content of the virus preparations was determined by the Lowry method (8) with 3.5 mM 
sodium dodecyl sulfate in the reaction mixture. 
Sendai virus (SV) was grown in the allantoic avity of 10-d-old embryonated chicken eggs. 
The virus was concentrated from the allantoic fluid by centrifugation at 120,000 g for 1 h at 
4°C. It was resuspended in phosphate-buffered saline (PBS) and purified by density-gradient 
centrifugation (20-50% sucrose (wt/vol)) in PBS at 100,000 g for 2 h at 4°C. Purified SV was 
inactivated with/~-propiolactone (BPL) (9). Proteolytic digestion of BPL-treated SV (BPL-SV) 
was achieved either by trypsin, which cleaves the fusion protein (F) (10), or by V8 protease 
from Staphylococcus aureus which removes the hemagglutinin-neuraminidase (HN) glycoprotein 
(2). 
Antisera. Mouse anti-SFV serum was prepared by inoculating 104 plaque-forming units 
(pfu) of SFV A774 strain (11) i.p. into BALB/c mice. The mice were bled 17 d after infection 
(BALB/c a-SFV). Rabbit anti-SFV serum (Rab a-SFV) was prepared by immunizing rabbits 
with purified spike proteins of SFV in the oetamer complex (protein micelles) form. It was 
kindly provided by Dr. K.. Simons, European Molecular Biology Laboratory, Heidelberg, 
Federal Republic of Germany. Mouse anti-SV serum was raised in DBA/2 mice by three 
injections of 100 hemagglutinating units i.p. at weekly intervals. The mice were bled 15 d after 
the last injection (DBA/2 a-SV). Rabbit anti-SV(F) serum was an antiserum against purified 
SV F. It was kindly a provided by Dr. M.-J. Gething, Imperial Cancer Research Fund, London, 
England. Anti H-2 serum was prepared by 6-10 repeated immunizations ofCBA/J mice with 
107 spleen cells from a BALB/c mouse (CBA/J a-BALB/c) i.p. Anti-non-H-2 serum was 
obtained by grafting DBA/2 skin onto B10.D2 mice followed 22 and 32 d later by a challenge 
with 10 v DBA/2 spleen cells i.p. (B10.D2 a-DBA/2). It was a gift from Dr. Berenice Kindred, 
Heidelberg, Federal Republic of Germany. 
Complement. Normal rabbit serum, absorbed with mouse spleen cells, served as a source of 
complement when using P815 cells as target cells. Normal guinea pig serum (Behring Werke 
AG, Marburg/Lahn, Federal Republic of Germany), absorbed with agarose and sheep eryth- 
rocytes, was used in CDL assays using Eb cells as target cells. 
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F1o. 1. Schematic drawing of the preparation ofSFV antigens in different physical forms andof 
their use in target cell generation showing three different characteristics of antigen presentation: (a)
cells expressing the viral antigens bound to receptors on the cell surface by attachment ofSFV-29S 
complexes or by incubation with SFV-virosomes, (b) cells expressing the viral antigens integrated in
the cell membrane from within by SFV infection, and (e) cells expressing the viral antigens 
integrated inthe cell membrane from without by incubation with virosomes from SFV under fusion 
conditions. TX 100, Triton X-100. 
Effector Cells 
K (]ELLS. Human peripheral blood lymphocytes obtained by the Isopaque-Ficoll (Phar- 
maeia Fine Chemicals Inc., Div. of Pharmacia, Inc., Piscataway, N. J.) separation method (12), 
were used as effeetor cells in ADCC assays. 
CTL. Anti-SV-speeific CTL were generated as described (13). They were secondary CTL 
from DBA/2 mice sensitized in vivo and restimulated in vitro. 
Target Cells. The tumor cell lines P815 (a mastocytoma cell) and Eb (a lymphoma cell) (14) 
are both derived from DBA/2 (H-2 d) mice. They were grown in suspension culture at 37°C in 
a 5% CO2 atmosphere using RPMI-1640 medium supplemented with 10% fetal calf serum, 2 
mM L-glutamine, 50 U/ml  penicillin 50 #g/ml streptomycin, and 10 mM Hepes, pH 7.3 
(complete RPMI-1640 medium). The cells were harvested in the exponential growth phase. 
fil 6 They were incubated with viral antigens and labeled with 25 gCi Cr per 10 cells at the same 
time (see below for incubation times). Before using the cells in a cytotoxic assay, they were 
washed and the viability was determined by trypan blue exclusion. Target cells carrying the 
virus spikes integrated into the cell membrane from within were prepared for one cycle of 
infection by incubation with 10-100 pfu of SFV per cell in serum-free medium for 1 h at 37°C 
in a total vol of 200 ~1. Thereafter, 1 ml of complete RPMI-1640 medium was added per l0 s 
cells and they were further incubated for 3 h. 29S complexes from SFV were bound to the cell 
6 surface by incubation of 5-10 #g of the mieelles per 10 cells in RPMI-1640 medium buffered 
to pH 7.0 or to pH 6.5 with 2-(N-morpholino)ethane sulfonic acid (MES). Virosomes were 
bound to the cell surface by incubation of 2-5 p.g virus protein with the cells under similar 
conditions as for the 29S complexes. Integration of SFV membrane protein into the cell 
membrane from outside was achieved by incubation of cells with 5 #g virosomes per 106 cells 
and with SV with active fusion activity (amounts pecified in legends to figures) for 1-4 h at 
37°C in complete RPMI-1640 medium. 29S complexes (10 #g/10 cells) were also incubated 
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with SV as described for virosomes. Further controls included incubation ofcells with virosomes 
and SV with inactivated HN or F. 
Assays 
INDXRECT IMMtrr~OFLUORESCENCE (nv). IIF was performed as described by M611er (15). 106 
cells in 40/xl medium and 10 p.l 1:10-diluted Rab c~-SFV serum were incubated for 30 min on 
ice. The cells were washed twice and suspended in 50 /~1 medium plus 50 /xl l:50-diluted 
fluorescein isothiocyanate (FITC)-conjugated pig anti-rabbit Ig serum (Nordic Immunological 
Laboratories, Tilburg, The Netherlands) and incubated further on ice for 30 min. The cells 
were washed twice in PBS, pH 7.4, and fixed in 50 #1 of 1.8% paraformaldehyde at room 
temperature for 10 min. Thereafter, the cells were washed again in PBS and mounted on glass 
slides. In the case where the cells were coated with virosomes or micelles, the medium used was 
buffered to pH 6.5 with MES except for the mounting buffer, which had a pH of 7.4. The 
above antisera were always preabsorbed with the same cells on which they were used. 
ANT1~ODY A~soar, rxoN. 1 ml of antiserum was preincubated with 1.2 × 107 of the different 
target cells for 30 rain on ice and the remaining cytolytic activity of the antiserum was tested 
by CDL of SFV-infected target cells. 
COMPLEMENT CONSUM~rxoN. The hemolytic omplement activity left in the supernate of 
CDL was determined asdescribed (16). 
IMMUNE c~CrOLYSlS ASSAYS. The cytolysis of target cells was assayed in a 5XCr-release t st (17, 
18), performed in round-bottom icrotiter plates (Linbro Chemical Co., Hamden, Conn., 
model IS-MRC 96). In CDL 2 × 104 target cells in a vol of 25 ~1 were incubated with 25/~1 
diluted antiserum and 25 p.l complement for 1 h at 37°C. After incubation, 125 ~tl of cold 
medium was added. In ADCC 2 X 104 target cells in a vol of 75/~1 were incubated with 25 ~1 
diluted antiserum and 1 × 106 effector cells in 100/~1 for 4 h at 37°C. In T-cell lysis (CTL) 1 
x 104 target cells in 100/~1 of medium were incubated together with four different concentra- 
tions of effector cells for 4 h at 37°C. In all cytolysis assays the plates were centrifuged at the 
end of the incubation period for 10 min at 375 g. 100 ~1 samples of the supernates were removed 
and the radioactivity determined in a gamma counter (Wallac Ultrogramma; LKB Produkter, 
Bromma, Sweden). Results are given as the percentage of specific SXCr release and were 
calculated from triplicates according to the formula: 
experimental counts per minute - low control 
percentage ofspecific 51Cr release -- high control - low control × 100. 
High controls were obtained by incubation of the target cells with detergent. The release from 
cells incubated without antiserum but in the presence of complement is referred to as low 
control in CDL. In the ADCC and T-cell lysis systems, the spontaneous release of target cells 
incubated without effector cells was taken as low control. 
Resul ts  
Binding and Redistribution fSFV Spike Glycoprotein o  Murine Tumor Cell Lines. Before 
starting the cytolysis assays, the optimal conditions for b inding of the viral antigens 
to the murine target cells (P815 and Eb) were determined by IIF. With 29S complexes, 
maximum intensity of fluorescence was obtained with 10/.tg of spike protein per 106 
cells, after incubation on ice for 30 rain at pH 6.5. 2 Fluorescence was detectable using 
as little as 0.5/~g of spike protein. With virosomes a max imum intensity of fluorescence 
was obtained with 2-5 /~g of spike protein/106 cells. More than 95% of the cells 
incubated with the 29S complexes or the virosomes howed fluorescence which under 
noncapping conditions had a patchy distribution (Fig. 2 A and B). After infection of 
Eb or P815 cells with SFV, >95% of the cells were again positive in I IF (Fig. 2 C). No 
fluorescence was observed with control cells without viral antigens. 
Redistribution of viral antigens on the tumor cell membranes was investigated after 
2 For pH dependence of the binding see (19). 
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incubation of the antibody-coated cells at 37°C. More than 90% of the cells showed 
cap formation after incubation with 29S Complexes and rabbit anti-viral antibodies, 
followed by incubation f r 2 h at 37°C with the FITC-eonjugated pig or sheep anti- 
rabbit Ig (Fig. 2D). When the capped cells were again incubated with the 29S 
complexes and assayed in IIF with rhodamine-conjugated sheep anti-rabbit serum no 
fluorescence was observed on the stripped areas of the cell. 
Target Cells with Viral Antigens Attached to the Cell Membrane are Resistant o Immune 
Cytolysis. P815 cells carrying viral antigens as integral membrane proteins after 
infection with SFV, were lysed by anti-SFV antiserum and complement (Fig. 3). 3 No 
target cell lysis, however, was seen when the tumor cells carrying SFV 29S complexes 
(Fig. 2A) were incubated with anti-SVF serum and complement under the same 
conditions (Fig. 3). In spite of their resistance to lysis, the target cells bound antibody 
and consumed even more complement than the virus-infected cells (Table I). 
To exclude the possibility that the cells after attachment of viral antigens were 
generally resistant o lysis, several antisera against other cell surface determinants 
were tested. As illustrated in Fig. 3, an antiserum against non-H-2 membrane antigens 
(B10.D2 a-DBA/2) lysed untreated, virus-infected and 29S-coated target cells with 
equal efficiency. When using an antiserum against H-2 antigens, 29S-coated cells 
were generally lysed less efficiently than untreated or virus-infected cells. This blocking 
effect of H-2-specific lysis by 29S complexes was found with reproducibility in l0 out 
of 12 experiments and ranged between 20 and 70% inhibition. 
Analogous experiments were performed with a different immune cytolysis tech- 
nique, ADCC, in which K cells are added to the system instead of complement. The 
results obtained in ADCC were very similar to those obtained in C:DL (Fig. 4). Thus, 
the inability of anti-virus antibody to lyse target cells carrying SFV-29S complexes on 
the surface, does not seem to be restricted to the complement system. 
Target Cells with Viral Antigens Integrated into the Cell Membrane via Fusion are Susceptible 
to Immune Cytolysis. The difference in susceptibility to lysis of virus-infected cells and 
29S complex-coated cells suggested that integration of viral antigens into the cell 
membrane may be required for immune cytolysis. To test this hypothesis directly, we 
tried to integrate the purified viral antigens from outside into the cell membrane via 
fusion of SFV virosomes as outlined in Fig. 1. The target cells incubated with SFV 
virosomes were sistant to lysis by anti-SFV antibody and complement (Figs. 3 and 
5). The cells, however, became susceptible for SFV-specific lysis when together with 
SFV virosomes BPL-treated SV was added as a fusing reagent (Fig. 5C). Ceils 
incubated with SFV-29S complexes remained resistant to lysis even in the presence of 
SV. 
The same target cell preparations were also tested in the ADCC assay. The results 
(Fig. 6) were in every aspect analogous to those reported above for the CDL test. 
Thus the K cells in the presence of antibody to SFV lysed target cells incubated with 
virosomes and SV with fusion activity, but not cells incubated with 29S complexes 
and the same preparation of SV. 
Further evidence for fusion of the virosomes with the cell membrane as the decisive 
factor which made the cells susceptible to immune lysis was obtained from control 
a This lysis appears to f llow the alternative pathway of complement activation ([20] and Barz et al. 
Manuscript in preparation.). 
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FIG. 2A, B 
Fro. 2. IIF of target cells. (A) P815 cells incubated with SFV-29S complexes. × 4,000. (B) P815 
cells incubated with SFV-virosomes. X 1,500. (C) P815 cells infected with SFV. × 4,000. (D) P815 
cells incubated with SFV-29S complexes under capping conditions. × 15,000. 
experiments with SV preprations lacking the fusion capacity: (a) trypsin-treated SV 
(Tryp-SV), which has similar b inding capacity as BPL-SV but carries an inactive F 
and (b) staphylococcus protease-treated SV (Staph-SV), which lacks the HN protein 
and therefore cannot b ind and mediate fusion. These and the untreated SV prepa- 
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Fig. 2 C, D 
rations were tested not only for their capacity to mediate SFV-specific lysis but also 
to function as targets for SV-specific lysis (CDL, ADCC). In addition, SV-specific T- 
cell mediated lysis was tested which was previously found to be a very sensitive assay 
for the detection of membrane-integrated SV. The results (Figs. 5 and 6) showed: (a) 
SFV-specific lysis via virosomes (CDL, ADCC) was not facilitated by SV preparations 
without fusion capacity; (b) in tests for SV-specific lysis (CDL, ADCC), only the SV 
preparation with fusion capacity was able to generate appropriate target cells. 
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Fla. 3. CDL of P815 cells expressing SFV spike protein by virus infection or by attachment of the 
purified spike proteins as 29S complexes or virosomes. (O) Nontreated P815 cells; (ll) SFV-infected 
P815. cells; (&) P8t5 cells with SFV-29S complexes bound to the cell surface; (0) P815 cells with 
SFV-virosomes bound to the cell surface. 
TABLE I 
Binding of Antibody and of Complement to Cells Infected with SFV or Coated with SFV-29S Complexes 
Conditions in CI)L Noatreated cell,, SFV-infccled ~e|ls 
Antiserum C' 
Ct~lls + SFV-29S complexes 
Remain- Remain- Remain- Renlain- Remain- Remain- 
~lCr re- ing corn- ing anti- ~lCr' re- in n corn ing anti ;ICr re- ing corn- ing anti- 
lease* plement body a~.- lease* plcment body ac- lease* plement body ac- 
actlvity:~ tivity§ activity~ tivlty§ activity:~ tiviu, § 
,;, ,/, ,,, 
-- -- 4 7 - -  6 7 - -  9 9 - -  
+ 5 41 - -  7 32 - -  t 0 30 --- 
Rabbit a-.'SFV + 4 43 71 52 15 26 9 9 9 
1:25 
CBA a-BALB/c + 78 24 9 82 22 7 76 27 9 
1:25 
The capac i ty  o f  the different arget cells to bind specific antibodies and complement (C') was compared with  their ability to mediate C|)I,. 
* The percentage of nSCr release of the different Eb target cells in a CI)L test. 
:~ The percentage of remaining hemolytic activity of the complement in supernates of CD1.  test performed analogous to those in the 51Cr-r'elease assay 
but with unlabeled target cells: for each  group  3-5 samples of supernate were pooled and tested against sensitized eiythrocytcs as described [16) 
§ The percentage of remaining cytolytic activity of the antiserum when preabsorbed on either nontreated, SFV-infccted, or 29S conlplex-coated cells 
(P815} and then tested in a Cl/ I ,  test on SFV-infected P815 target cells; fol conditions of the absorption, see Material and Methods. 
All the differently treated target cells could be lysed by H-2 alloantibodies and 
complement.  
When testing the same target cell preparations for susceptibility to immune cytolysis 
by specific CTL, similar results were obtained again (Fig. 7). SV-specific CTL were 
shown to lyse only those tumor target cells which were sensitized with BPL-SV 
carrying active HN and F. When either of these proteins was destroyed or inactivated 
by enzymatic pretreatment, no sensitization of target cells for lysis was observed. 
Incubation of ceils with 0.1 #g of SV was found sufficient for target cell formation in 
the CTL assay, but incubation with even 50 ~g of Tryp-SV or Staph-SV did not 
make the cells susceptible to SV-specific immune lysis. 
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with SFV-virosomes bound to the cell surface. 
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Discussion 
Integration of a virus membrane protein into the lipid bilayer of target cells has 
been shown to be essential for immune cytolysis. This came out from experiments in
which the spike proteins of SFV were incorporated into target cell membranes from 
outside via fusion of virosomes. This kind of experiment demonstrating the successful 
transfer of a purified membrane protein from one particle (the virus) to another (the 
tumor target cell) may be of general applicability and will therefore be discussed in 
more detail. 
The spike proteins of SFV were first isolated in detergent. Because the detergent 
would interfere with the stability of the target cell membranes, it was either replaced 
by artificial lipids whereby the SFV proteins were reconstituted into lipid vesicles 
(virosomes) or it was removed completely, whereby the spike proteins formed stable 
octamerous rosettes (29S complexes). Both the virosomes and the 29S complexes had 
the ability to attach to the murine tumor target cells. Such cells with attached SFV 
antigens could not be 1ysed by anti-SFV antibody and complement (CDL) or by anti- 
SFV antibody and K cells (ADCC). When, however, fusion between the SFV- 
virosomes and the target cell membranes was made possible by the addition of 
noninfectious SV as a fusing reagent, SFV-specific lysis was observed in both the CDL 
and the ADCC assay. Cells with attached SFV-29S complexes remained resistant o 
SFV-specific lysis even in the presence of the above SV preparation. 
These studies can be considered as an extension of previous liposome-cell interaction 
experiments which enabled the introduction of the haptenic determinant dinitro- 
phenyl into target cell membranes (21, 22, 23). The new aspects from our system are: 
(a) use of a natural membrane protein (SFV) rather than a lipophilic artificial 
substance; (b) comparison of different physical forms of the same membrane protein; 
and (c) separation of the fusion process itself by using an independent and well- 
characterized antigenic system as mediator for fusion. Thus it could be shown that 
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FIo. 6. ADCC of Eb cells incubated with SFV-purified spike protein as 29S complexes or virosomes 
in the absence or presence of SV with an active or inactive F. 25 #g of the SV preparations were 
added to 10 e cells. (A) O C), Nontreated Eb cells; Q) - - -O ,  Eb cells incubated with SV; 
O . . .O ,  Eb cells incubated with Tryp-SV; O- . -O ,  Eb cells incubated with Staph-SV. (B) 
• • ,  Eb cells incubated with SFV-29S complexes; • - -  -&, Eb cells incubated with SFV-29S 
complexes and with SV. (C) O- - - -O ,  Eb cells incubated with SFV-virosomes; 0 - - -0 ,  Eb cells 
incubated with SFV-virosomes and with SV; 0 . . .0 ,  Eb cells incubated with SFV-virosomes and 
with Tryp-SV; O- . -O ,  Eb ceils incubated with SFV-virosomes and with Staph-SV. 
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FIC. 7. SV-specific T-cell-mediated lysis of target cells incubated with SV with an active or 
inactive F in the absence or presence of virosomes from SFV. CTL were derived from DBA/2 spleen 
cells sensitized against SV. (A) O O, Nontreated P815 cells; O- - -O, P815 ceils incubated with 
SV; 4,------~, P815 cells incubated with SFV-virosomes; 0 - - -0 ,  P815 cells incubated with SFV- 
virosomes and with SV. (B) O O, Nontreated Eb cells; O- - -O, Eb cells incubated with SV (0.1 
/~g/106 cells); O . . .O ,  Eb cells incubated with Tryp-SV (50 #g/106 cells); O- - -O,  Eb ceils incubated 
with Staph-SV (50 #g/106 cells). 
cells incubated with SFV-virosomes could be lysed by anti-SFV antibodies only when 
SV preparations were added which could bind to and fuse with the target cell 
membrane. SV preparations which could still bind but not fuse because the F had 
been inactivated by pretreatment with trypsin did not facilitate SFV-specific lysis, 
even when offered in a 500-fold excess. Separate controls with anti-SV antibodies or 
anti-SV CTL demonstrated that only those preparations which allowed SV-specific 
lysis and thus contained fusion activity also facilitated SFV-specific lysis. 
The stringent dependency of SFV-specific lysis on fusion between SFV-virosomes 
and the target cells excludes everal alternative mechanisms of antigen transfer which 
could hitherto not be excluded in published studies on liposome cell interactions: (a) 
simple diffusion, which can account for transfer of lipid molecules from bilayer vesicles 
upon contact with cell membranes (24, 25), (b) phagocytosis, driven by metabolic 
energy, and (c) engulfment, driven by surface-tension effects. The data are more 
adequately explained by vesicle-cell membrane fusion. Although the sequence of 
events at the molecular level is not known, it could be anticipated to proceed via 
vesicle-cell attachment, lipid bilayer perturbation brought about by the F of SV, and 
integration of the SFV spike protein together with adjacent artificial lipid into the 
target cell membrane (26). Fusion activities have been reported for liposomes in the 
absence of a specific fusing reagent. Such liposomes had to have a low transition 
temperature (high fluidity) and a positive charge. However, neutral iposomes with 
high fluidity such as phosphatidylcholine from egg yolk as were used in the present 
study were reported not to fuse spontaneously with cells (27). 
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Recent studies with inactivated SFV rather than virosomes indicate that very 
similar results can be obtained (D. Barz. Unpublished observations.): target ceils 
coincubated with SFV in the absence of a fusing reagent were resistant to SFV- 
specific lysis, whereas in the presence of a fusing reagent, they became susceptible. It
thus seems that even the virus itself does not fuse spontaneously with the target cell 
membrane. It was recently demonstrated that SFV can enter target cells via endocy- 
tosis of membrane-bound viruses in coated vesicles and that these were the first steps 
on a pathway leading to productive cell infection (28). Together with our observations 
these studies indicate that SFV can enter target cells without fusing with the plasma 
membrane and thus without introducing susceptibility to immune cytolysis. With the 
help of a fusing reagent, however, it seems to be possible to induce fusion of SFV or 
virosomes with target cell membranes and to integrate the viral spike proteins. 
Electron-micrograph studies are underway to visualize this process of induced fusion. 
The above interpretation of vesicle-membrane fusion could also explain why the 
cells coated with the SFV-29S complexes, even in the presence of a fusing reagent, 
could not be lysed by anti-SFV antibodies. These protein micelles, as a result of a lack 
of lipid cannot fuse with membranes. They are held together by the hydrophobic 
portions of the individual membrane proteins which interact with each other in the 
center of the complex. Studies by Helenius and Bonsdorff (4) and Helenius et al. (5) 
have shown that the 29S complexes are very stable, difficult to break, and not suitable 
for reconstituiton i to liposomes (A. Helenius. Personal communication.). Neverthe- 
less, it could be argued that the resistance to immune lysis of the cells carrying SFV 
antigens merely bound to the surface is a peculiarity of the SFV system and perhaps 
a result of the fact that this virus binds to histocompatibility antigens. This seems 
unlikely because resistance to lysis was also observed with SFV-29S complexes bound 
to cells at low pH (6.0-6.5). At low pH, many more 29S complexes can be bound per 
cell than at neutral pH which was explained by additional non-specific (i.e., not H-2 
mediated) binding (19). Because many of the experiments presented were performed 
under low pH conditions, the resistance to immune cytolysis of these cells seems to be 
more of general significance. Furthermore, similar results were obtained in other virus 
systems, such as SV used as a control in these studies and vesicular stomatitis virus 
(29). Lysis obtained by antisera gainst other antigens than the viral proteins, e.g., 
non-H-2 antigens, excluded the possibility of intrinsic changes in the target cell 
membranes or in the membrane repair system (30). 
A separate finding was made when using anti-H-2 sera for control. Here a partial 
reduction was observed in the specific lysis when comparing 29S complex-coated with 
noncoated target cells. This blocking effect was (a) selective for anti-H-2 sera (directed 
against he private specificities of the K- and D-end molecules) and (b) more prominent 
with P815 than with Eb tumor target cells. The selective blocking observed with anti- 
H-2 sera is explained by our previous demonstration that SFV binds to H-2K and D 
molecules (6). The differences between Eb and P815 cells could be explained by the 
different numbers of SFV receptors determined (1.9 × 104/Eb cell and 0.2 × 104/ 
P815 cell) (19). The chance of anti-H-2 antibodies to find free H-2 determinants and 
to efficiently activate complement may thus be greater with Eb than with P815 cells. 
The following conclusions can be reached from these studies: (a) integration of viral 
antigens into the lipid bilayer of target cells appears as a prerequisite for immune 
cytolysis; (b) immune eytolysis by antibody and complement (CDL), antibody and K 
cells (ADCC), and by specific CTL share this prerequisite which may indicate a 
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common mechanism of at least part of the lytic process; (c) cytolysis assays may serve 
as sensitive tests for membrane fusion and for integration of a protein into the lipid 
bilayer; these tests have already been used for this purpose (22, 23) but no formal 
proof for the validity of this assumption has existed so far; and (d) the transfer of 
membrane antigens via vesicles and a fusing reagent into the membranes of ther 
cells may find a useful application in virus or tumor systems to define the target 
molecules involved in immune cytolysis. 
Summary  
Structural requirements for membrane antigens on target cells to mediate immune 
cytolysis were studied in a model system with purified membrane proteins from 
Semliki Forest virus (SFV). These SFV spike proteins were isolated in the form of 
detergent- and lipid-free protein micelles (29S complexes) or, after reconstitution i to 
lipid vesicles, in the form of virosomes. Both the 29S complexes and the virosomes 
were found to bind well to murine tumor cells (P815 or Eb). When these cells, 
however, were used as target cells in complement-dependent lysis or in antibody- 
dependent cell-mediated cytotoxicity assays in the presence of anti-SFV serum, they 
were not lysed, although they effectively bound the antibody and consumed comple- 
ment. The same tumor cells infected with SFV served as positive controls in both 
assays. 
Different results were obtained when inactivated Sendai virus was added as a fusion 
reagent to the cells coated with either virosomes or 29S complexes. Under these 
conditions the virosome-coated cells became susceptible to SFV-specific lysis, whereas 
the 29S complex-coated cells remained resistant. Evidence that the susceptibility to 
lysis ofvirosome-coated cells was dependent on active fusion and, therefore, integration 
of the viral antigens into the lipid bilayer of the target cells was derived from control 
experiments with enzyme-treated Sendai virus preparations. 
The 29S complexes and the virosomes partially and selectively blocked the target 
cell lysis by anti-H-2 sera but not by anti-non-H-2 sera confirming our previous 
finding that major histocompatibility antigens erve as receptors for SFV. The general 
significance of these findings for mechanisms of immune cytolysis is dicussed. 
We wish to thank Dr. A. Helenius and Dr. K. Simons from the EMBL, Heidelberg, for their 
help and advice in preparing the SFV viral antigens. We are also grateful to Dr. B. Kindred, 
Dr. M.-J. Gething, and Dr. K. Simons for kindly providing us with specific antisera nd Dr. W. 
Rauterberg, University of Heidelberg, for help with the complement consumption assay. The 
technical assistance of Mrs. Iris Neuschiifer-Rube and Mrs. Doris Hfibsch and the typing 
assistance of Mrs. Heidrun Zimmermann and Mrs. Ursula Rohmann is gratefully acknowl- 
edged. 
Received for publication 24 May 1979. 
References 
1. Koszinowski, U., M.-J. Gething, and M. D. Waterfield. 1977. T-cell cytotoxicity in the 
absence of viral protein synthesis in target cells. Nature (Lond.) 267:160. 
9. Gething, M. J., U. Koszinowski, and M. D. Waterfield. 1978. Fusion of Sendai virus with 
target cell membrane is required for T cell cytotoxicity. Nature (Lond.). 274:689. 
3. Simons, K., A. Helenius, and G. Garoff. 1973. Solubilization of the membrane proteins 
from Semliki Forest virus with Triton X-100J. Mol. Biol. 80:119. 
 o
n
 N
ovem
ber 12, 2012
jem.rupress.org
D
ow
nloaded from
 
Published December 1, 1979
96 I I  CY L I  FTER E-TARGET I  
mon chanism t st rt e ic oces ; Ce) tolysis ssays y rve 
s nsitive sts r mbrane sion d r tegration  tein o e  
il yer; ese sts ve l ready en ed r is rpose 2, ) t  r al 
of r e lidity is ssumption s isted  r; d ) e ansfer 
mbrane tigens  sicles d  sing agent o e mbranes of er 
l s y   eful plication s  or stems  fine e rget 
lecules olved  une tolysis. 
ary 
ructural quirements r mbrane tigens  target l s  diate une 
tolysis re tudied   del stem  rified mbrane teins  
liki st s . se ike teins re lated e form 
tergent- d i -free tein icelIes 9S plexes) , fter consti ution o 
 sicles, e form somes.  e S plexes d e osomes 
re nd   il  rine or l s SIS  . n ese l s, 
ever, wer  ed s rget l s plement-depende t is   tibody-
pendent ll- ediated totoxicity ssays  e esence ti-SFV rum, ey 
re t ed, lthough ey ffectively nd e tibody d nsumed ple-
nt.  e or l s cted  rved s sitive ntrols  th 
ssays. 
rent sults re tained n ctivated ndai s s ded s  sion 
agent  e l s ated  either osomes  S plexes. r ese 
nditions the osome-coated l s came sceptible  ecific is, reas 
e S plex-coated l s ained sistant. ence t e sceptibility  
is  osome-coated l s s pendent  tive sion d, erefore, tegration 
e l tigens into e  i yer e rget l s s rived  ntrol 
periments  zyme-treated ndai s eparations. 
 S plexes d e osomes rtially d lectively l cked the target 
l  is  ti-H-2 ra t t  ti-non-H-2 ra nfirming r evious 
ing at jor i tocompatibility tigens rve s ceptors r  neral 
i nificance ese ings r chanisms une tolysis  i us ed. 
 i h  ank .  lenius d .  ons m e , idelberg, r eir 
lp d dvice  reparing e al ntigens.  re lso rateful  . . red, 
. .-j. thing, d . K i ons r dly roviding s h ecif c tisera d . . 
uterberg, i ersity  idelberg, r lp h e plement nsumption ssay.  
chnical ssistance  . Iris schäfer-Rube d . ris ü sch d e ping 
ssistance  . i run ermann d . ula an   ratefully cknowl-
dged. 
ceivedf r blication  y 1979. 
rences 
. zinowski, u., M.-j  thing, d  terfield. 97 . l  totoxic ty  e 
bsence  al rotein nthesi  in rget l s. ture (Lond.) 7: 160. 
2. thing, j  szinowski, d  terfield. 978. sion  ndai us h 
rget l  embrane  quired r el  totoxic ty. ture (Lond.). 4:689. 
. ons,  lenius, d . rof . 973. lubilization  e embrane roteins 
m liki rest us h n WO]. l. iol. :119. 
B. MOREIN, D. BARZ, U. KOSZINOWSKI, AND V. SCHIRRMACHER 1397 
4. Helenius, A., and C. H. Bonsdorff. 1976. Semliki Forest virus membrane proteins. Prepa- 
ration and characterization f ipike complexes soluble in detergent-free medium. Biochim. 
Biophys. Acta 436:895. 
5. Helenius, A., E. Fries, and J. Kartenbeck. 1977. Reeonstitution of Semliki Forest virus 
• membrane..]. Cell Biol. 75:866. 
6. Helenius, A., B. Morein, E. Fries, K. Simons, P. Robinson, V. Schirrmacher, C. Terhorst, 
and J. L. Strominger. 1978. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) 
histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc. Natl. 
Acad. Sci. U. S. A. 75:3846. 
7. K~iiiri~iinen, L., K. Simons, and C. H. yon Bonsdorff. 1969. Studies on subviral components 
of Semliki Forest virus. Ann. Med. Exp. Biol. Fenn. 47:235. 
8. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R.-J. Randall. 195 I. Protein measurement 
with the Folin phenol reagent. J. Biol. Chem. 193:265. 
9. Seheid, A., and P. W. Choppin. 1974. Identification ofbioiogical activities ofparamyxovirus 
glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic leavage 
of an inactive precursor protein of Sendal virus. Virology. 57:475. 
10. Shimizu, Y. K., and N. Ishida. 1975. The smallest protein of Sendai virus: its candidate 
function of binding nucleocapsid to envelope. Virology. 67:427. 
11. Bradish, C. J., B. Allner, and H. B. Maber. 1971. The virulence of original and derived 
strains of Semliki Forest virus for mice, guinea-pigs and rabbits. J Gen. Virol. 12:141. 
12. B0jum, A. 1968. Isolation of leucocytes from human blood. A two phase system for removal 
of red cells with methyl cellulose as erythroeyte-aggregating agent. Scand. J Clin. Lab. Invest. 
21 (Suppl. 9):4. 
13. Koszinowski, U., and M. M. Simon. Generation of virus specific ytotoxic T cells in vitro. 
I. Induction conditions of primary and secondary Sendai virus specific eytotoxic T cells. 
Eur. J. Immunol. In press. 
14. Schirrmacher, V., G. Shantz, K. Clauer, D. Komitowski, H.-P. Zimmermann, and M.-L. 
Lohmann-Matthes. 1979. Tumor metastasis and cell-mediated immunity in a model system 
in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int. J. 
Cancer. 23"233. 
15. M611er, G. 1961. Demonstration f mouse isoantigens atthe cellular level by the fluorescence 
antibody technique.J. Exp. Med. 114:415. 
16. Hudson, L., and F. C. Hay. 1976. Practical Immunology. Blackwell Scientific Publications, 
Ltd., Oxford. 134. 
17. Wigzell, H. 1965. Quantitative titration of mouse H-2 antibodies using ~Cr labelled target 
cells. Transplantation (Baltimore). 3:423. 
18. Sanderson, A. R. 1964. Cytotoxic reactions of mouse isoantisera: preliminary consideration. 
Br. J. Exp. Med. 45:398. 
19. Fries, E., and A. Helenius. 1979. Binding of Semliki Forest virus and isolated viral spike 
glyocproteins to cells. Eur. J. Biochem. 97:213. 
20. Ehrnst, A. 1977. Complement activation by measles virus cytotoxic antibodies: alternative 
pathway C activation by hemagglutination-inhibition antibodies but classical activation 
by hemolysin antibodies. J. Immunol. 118:533. 
21. Uemura, K., and S. Kinsky. 1972. Active vs passive sensitization of liposomes toward 
antibody and complement by dinitrophenylated derivatives of phosphatidylethanolamine. 
Biochemistry. 22:4085. 
22. Martin, F. J., and R. C. MacDonald. 1976. Lipid vesicle-cell interactions. III. Introduction 
of a new antigenic determinant into erythrocyte membranes.J. Celt Biol. 70:515. 
23. Ozato, K., and C. Henney. 1978. Liposomes as model membrane systems for immune 
attack. I. Transfer of antigenic determinants o lymphocyte membranes after interactions 
with hapten-bearing liposomes.J. Immunol. 121:1376. 
24. Pagano, R. E., and L. Huang. 1975. Interaction of phospholipid vesicles with cultured 
 o
n
 N
ovem
ber 12, 2012
jem.rupress.org
D
ow
nloaded from
 
Published December 1, 1979
.  . , . I SKI, . I  97 
. lenius, , d  sdorff. 76. mliki Forest us embrane roteins. pa-
tion d aracterization .pike plexes solub e  tergent-free dium. i chim. 
i phys. ta 6:895. 
. lenius, ,  i s, d j. tenbeck. 97 . consti u ion mliki Forest irus 
embrane. J. G l  Biol. :86 . 
. lenius, ,  in,  i s,  ons,  inson, hir macher, rhorst, 
d j.  rominger. 978. an d d rine  d ) 
istocompatibility tigens re l  rface ceptors r mliki Forest us. oc. tl. 
ad. ei. . . . :3846. 
. ääriäine ,   ons, d  v n sdorff. 969. udies  bviral ponents 
mliki Forest us. n. d. p. io!. nn. :235. 
. ry,    j. ebrough,  rr, d j ndal!. 51  tein easurement 
h e lin enol agent. iol. G em. 3:265. 
. cheid, , d   ppin. 974. ntification f iological ctivities f aramyxovirus 
l coproteins. ivation l  sion, molysi , d fectivity  roteolytic 1 avage 
 ctive recursor rotein nd ai us. iTology. :475. 
0. i izu, d  ida. 975.  allest rotein ndai irus: s ndidate 
ction  i ding cleocapsid  nvelope. irology. :427. 
1. dish,  j  r, d  er. 971.  ulence riginal d rived 
trains mliki rest us r ice, inea-pigs d bbits.J. en. Virol. 2: 141. 
2. !6 ,  968. lation  ucocytes  an l od. o ase stem r oval 
d l s h ethyl l ulose s rythrocyte-aggregatin  gent. cand. . lin. Lab. vest. 
1 pp!. ):4. 
3. zinowski,  d  on. neration virus ecif c totoxic l s in itro. 
uction nditions ri ary d condary ndai us ecif c cytotoxic l s. 
r. . munol. res . 
4. hir macher, v ,  antz, uer,  itowski, . ermann, d  
an -Matthes. 979. or etastasis d l -mediated unity   odel stem 
  ice.  or asiveness  tro d etastasis r ation  i o. f. .
ncer. :23 . 
5. öller,  61. onstration f ouse antigens t e l ular vel  e orescence 
ntibody chnique.J. p. d. 4:415. 
6. son,  d   y. 976. ctical unology. ckwell ientif c blications, 
., xford. 34. 
7. zell, 965. antitative titration ouse  ntibodies ing 51 r belIed rget 
l s. nsplantation altimore). : 23. 
8. nderson, 964. totoxic actions ouse isoantisera: reliminary nsideration. 
. . p. d. :398. 
9. i s,  d  lenius. 79. ing mliki Forest us d lated i al ike 
l ocproteins  l s. UT. . i chem. :213. 
. rnst,  97 . plement ctivation  easJes irus totoxic ntibodies: lternative 
thway ctivation  mag lutination-inhibition ntibodies t 1 ssical ctivation 
 molysin antibodies. . munol. 8:53 . 
. ura,  d . ky. 972. ive s s ive nsit zation osomes ard 
ntibody d plement  i itrophenylated rivatives osphatidylethanolamine. 
i chemistry. :4085. 
. tin, .j d   onald. 976.  sicle-cell teractions. n roduction 
 w ntigenic terminant to rythrocyte embranes. J. G l  Biol. 0:515. 
. to,  d  nney. 978. somes s odel embrane stems r une 
ttack. nsfer  ntigenic terminants t  I phocyte embranes fter teractions 
h pten-bearing somes.J. munol. 1:1376. 
. gano,  , d  ng. 975. eraction ospholip d sicIes h ltured 
1398 SPECIFIC CYTOLYSIS AFTER VIROSOME-TARGET CELL FUSION 
mammalian cells. II. Studies of mechanism. J. Cell Biol. 67:49. 
25. Inbar, M., and M. Shinitzky. 1974. Increase in cholesterol level in the surface membrane 
of lymphoma cells and its inhibitor effect on ascites tumor development. Proc. Natl. Acad. 
Sci. U. S. A. 71:2128. 
26. Lodish, H. F., and J. E. Rothman. 1979. The assembly of cell membranes. Sci. Am. 240:38. 
27. Poste, G., and D. Papahadjopoulos. 1976. Lipid vesicles as carriers for introducing materials 
into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle 
incorporation into cells. Proc. Natl. Acad. Sci. U. S. A. 73:1603. 
28. Hetenius, A., J. Kartenbeck, K. Simons, and E. Fries. 1980. On the entry of Semliki Forest 
virus into BHK-21 cells.]. Cell BioL In press. 
29. Fan, D. P., and B. M. Sefton. 1978. The entry into host cells of Sindbis virus, vesicular 
stomatitis virus and Sendai virus. Cell. 15:985. 
30. Schlager, S. J., S. H. Ohanian, and T. Borsos. 1978. Correlation between the ability of 
tumor cells to resist humoral immune attack and their ability to synthesize lipid.J, lmrnunol. 
120:463. 
 o
n
 N
ovem
ber 12, 2012
jem.rupress.org
D
ow
nloaded from
 
Published December 1, 1979
98 IFI  CYT LYSIS AFTER VIROSOME-TARGET  I  
ammalian ells_ 11. tudies echanism.]. G l  Biol. 7:49. 
5. ar,  d  initzky. 974. rease  olesterollevel  e rface embrane 
lymphoma l s d s ibitor ffect  scites or evelopment. e. Natl. Aead. 
ei,. . .  1:2128. 
. ish, H. , d j   thman. 979. The ssembly l  embranes. ei. . 0:38. 
7. ste, , d  pahadjop ulos. 976.  sicles as carrie s  troducing aterials 
to ltured l s: fluence sicle id position  echanism(s) sicle 
corporation i to l s. e. t!. ead. Sei. U. S. J3: 603. 
8. lenius,  j  rtenbeck, i ons, d  ries. 1980. On the ntry  mliki est 
irus into 1 ll ]. G l  l.  ress. 
9. n,  P., d . fton. 978.  ntry to st cells i dbis irus, sicular 
tomatitis virus and ndai us. G l . 5:985. 
. hlager, . j .  anian, d rsos. 978. rrelation twe n e bility 
or l s  resi t moral une ttack d eir bility  nthesize i .]. I murlOl. 
0:463. 
